Flavia Varano
About
Flavia Varano is a scholar working on Molecular Biology, Organic Chemistry and Physiology.
According to data from OpenAlex, Flavia Varano has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 58 papers in Organic Chemistry and 55 papers in Physiology. Recurrent topics in Flavia Varano's work include Adenosine and Purinergic Signaling (55 papers), Synthesis and Biological Evaluation (46 papers) and Receptor Mechanisms and Signaling (25 papers). Flavia Varano is often cited by papers focused on Adenosine and Purinergic Signaling (55 papers), Synthesis and Biological Evaluation (46 papers) and Receptor Mechanisms and Signaling (25 papers). Flavia Varano collaborates with scholars based in Italy, Brazil and Canada. Flavia Varano's co-authors include Daniela Catarzi, Vittoria Colotta, Guido Filacchioni, Alessandro Galli, Chiara Costagli, Claudia Martini, Stefano Moro, Maria Letizia Trincavelli, Ombretta Lenzi and Katia Varani and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and European Journal of Medicinal Chemistry.
In The Last Decade
Flavia Varano
85 papers receiving 2.0k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Flavia Varano Italy | 30 | 1.4k | 1.2k | 862 | 234 | 106 | 87 | 2.1k | ||
| Daniela Catarzi Italy | 30 | 1.5k 1.1× | 1.2k 1.0× | 913 1.1× | 244 1.0× | 125 1.2× | 102 | 2.3k | ||
| Vittoria Colotta Italy | 31 | 1.7k 1.2× | 1.3k 1.1× | 924 1.1× | 261 1.1× | 169 1.6× | 113 | 2.5k | ||
| Barbara Cosimelli Italy | 25 | 1.0k 0.7× | 652 0.5× | 223 0.3× | 137 0.6× | 151 1.4× | 87 | 1.7k | ||
| Philip J. M. van Galen United States | 16 | 400 0.3× | 610 0.5× | 723 0.8× | 187 0.8× | 40 0.4× | 21 | 1.1k | ||
| Sheryl J. Hays United States | 17 | 468 0.3× | 700 0.6× | 329 0.4× | 280 1.2× | 46 0.4× | 37 | 1.3k | ||
| Andrew W. Stamford United States | 22 | 479 0.3× | 604 0.5× | 245 0.3× | 245 1.0× | 187 1.8× | 51 | 1.5k | ||
| Francesca Deflorian United States | 24 | 373 0.3× | 1.3k 1.1× | 641 0.7× | 449 1.9× | 48 0.5× | 42 | 1.8k | ||
| Michio Ichimura Japan | 23 | 594 0.4× | 928 0.8× | 372 0.4× | 264 1.1× | 296 2.8× | 49 | 1.6k | ||
| Hamideh Zarrinmayeh United States | 23 | 725 0.5× | 927 0.8× | 109 0.1× | 286 1.2× | 136 1.3× | 38 | 1.5k | ||
| Giampaolo Primofiore Italy | 21 | 833 0.6× | 546 0.5× | 144 0.2× | 124 0.5× | 108 1.0× | 83 | 1.2k |
Countries citing papers authored by Flavia Varano
Since
Specialization
Citations
This map shows the geographic impact of Flavia Varano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavia Varano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavia Varano more than expected).
Fields of papers citing papers by Flavia Varano
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Flavia Varano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavia Varano. The network helps show where Flavia Varano may publish in the future.
Co-authorship network of co-authors of Flavia Varano
This figure shows the co-authorship network connecting the top 25 collaborators of Flavia Varano. A scholar is included among the top collaborators of Flavia Varano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavia Varano. Flavia Varano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Spinaci, Andrea, Michela Buccioni, Daniela Catarzi, et al.. (2023). “Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals. 16(2). 167–167.
2.
Cherchi, Federica, Ilaria Dettori, Daniela Catarzi, et al.. (2023). Pharmacological Characterization of P626, a Novel Dual Adenosine A2A/A2B Receptor Antagonist, on Synaptic Plasticity and during an Ischemic-like Insult in CA1 Rat Hippocampus. Biomolecules. 13(6). 894–894.
3.
Lambertucci, Catia, Gabriella Marucci, Daniela Catarzi, et al.. (2022). A2A Adenosine Receptor Antagonists and their Potential in NeurologicalDisorders. Current Medicinal Chemistry. 29(28). 4780–4795.
4.
Catarzi, Daniela, Flavia Varano, Fabrizio Melani, et al.. (2022). 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. Pharmaceuticals. 15(4). 478–478.
5.
Catarzi, Daniela, Flavia Varano, Catia Lambertucci, et al.. (2022). Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents forNeurodegenerative Disorders. Current Medicinal Chemistry. 29(27). 4698–4737.
6.
Varano, Flavia, Daniela Catarzi, Diego Dal Ben, et al.. (2021). Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of Depression. Pharmaceuticals. 14(7). 657–657.
7.
Falsini, Matteo, Daniela Catarzi, Flavia Varano, et al.. (2020). New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 30(11). 127126–127126.
8.
Varano, Flavia, Daniela Catarzi, Fabrizio Vincenzi, et al.. (2020). Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents. Bioorganic & Medicinal Chemistry Letters. 30(9). 127067–127067.
9.
Catarzi, Daniela, Flavia Varano, Matteo Falsini, et al.. (2019). Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity. Journal of Medicinal Chemistry. 62(15). 6894–6912.
10.
Falsini, Matteo, Daniela Catarzi, Flavia Varano, et al.. (2019). Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells. Bioorganic Chemistry. 87. 380–394.
11.
Falsini, Matteo, Daniela Catarzi, Flavia Varano, et al.. (2019). Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain. Journal of Medicinal Chemistry. 62(18). 8511–8531.
12.
Varano, Flavia, Daniela Catarzi, Fabrizio Vincenzi, et al.. (2018). Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2A adenosine receptor. European Journal of Medicinal Chemistry. 155. 552–561.
13.
Varano, Flavia, Daniela Catarzi, Matteo Falsini, et al.. (2018). Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1 and A2A adenosine receptor antagonists/inverse agonists. Bioorganic & Medicinal Chemistry. 26(12). 3688–3695.
14.
Catarzi, Daniela, Flavia Varano, Matteo Falsini, et al.. (2018). The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor. European Journal of Medicinal Chemistry. 150. 127–139.
15.
Varano, Flavia, Daniela Catarzi, Matteo Falsini, et al.. (2018). Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity. Bioorganic & Medicinal Chemistry Letters. 29(4). 563–569.
16.
Bonardi, Alessandro, Matteo Falsini, Daniela Catarzi, et al.. (2018). Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII. European Journal of Medicinal Chemistry. 146. 47–59.
17.
Colotta, Vittoria, Ombretta Lenzi, Daniela Catarzi, et al.. (2012). 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies. European Journal of Medicinal Chemistry. 54. 470–482.
18.
Colotta, Vittoria, Daniela Catarzi, Flavia Varano, et al.. (2005). Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring. European Journal of Medicinal Chemistry. 40(9). 897–907.
19.
Catarzi, Daniela, Vittoria Colotta, Flavia Varano, et al.. (2003). Synthesis and Biological Evaluation of Analogues of 7-Chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic Acid (TQX-173) as Novel Selective AMPA Receptor Antagonists. Journal of Medicinal Chemistry. 47(1). 262–272.
20.
Catarzi, Daniela, Vittoria Colotta, Flavia Varano, et al.. (2001). Synthesis, Ionotropic Glutamate Receptor Binding Affinity, and Structure−Activity Relationships of a New Set of 4,5-Dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates Analogues of TQX-173. Journal of Medicinal Chemistry. 44(19). 3157–3165.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Daniela Catarzi Breakdown of academic impact, for papers by Vittoria Colotta Breakdown of academic impact, for papers by Barbara Cosimelli Breakdown of academic impact, for papers by Philip J. M. van Galen Breakdown of academic impact, for papers by Sheryl J. Hays Breakdown of academic impact, for papers by Andrew W. Stamford Breakdown of academic impact, for papers by Francesca Deflorian Breakdown of academic impact, for papers by Michio Ichimura Breakdown of academic impact, for papers by Hamideh Zarrinmayeh Breakdown of academic impact, for papers by Giampaolo Primofiore